← Leaderboards
Mariana Nikolova-Karakashian
University Of Kentucky
$8,130,121
Attributed
$8,130,121
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $719.1K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$8,130,121 · 5
By mechanism
R01$7,680,431 · 3
R56$377,290 · 1
R03$72,400 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Kentucky
Same institution · by research overlap
- Debra Rateri$2,189,635
- Melinda E Wilson$1,891,554
- Victoria L King$2,567,541
Others in their field
Top investigators on “Ceramides”
- Yusuf Awni Hannun · Medical University Of South Carolina$31,236,776
- Besim Ogretmen · Medical University Of South Carolina$16,800,540
- Scott A Summers · Colorado State University-Fort Collins$15,094,141
- Pin-Lan Li · Medical College Of Wisconsin$14,567,134
- Richard N Kolesnick · Sloan-Kettering Inst Can Research$13,993,408
- Susan J Sumner · Research Triangle Institute$13,509,958
Research focus
CeramidesInflammationAgingPlayIn VivoIn VitroLinkHepatocyteResponseSphingomyelinaseLiverInflammatoryAgedOrganismElderlyRattusAnimalsCellsMapk8 GeneDoseUbiquitinationGenesAcute-Phase ProteinsTranscription Factor
Grant awards (27)
Signaling and metabolic functions of nSMase-2 in hepatic steatosis and onset of insulin resistance$580,341
R01 · FY2024 · DK · contact PI
Signaling and metabolic functions of nSMase-2 in hepatic steatosis and onset of insulin resistance$542,521
R01 · FY2023 · DK · contact PI
Ceramide and acute phase proteins elevation during aging$415,845
R01 · FY2022 · AG · contact PI
Ceramide and acute phase proteins elevation during aging$79,245
R01 · FY2022 · AG · contact PI
Ceramide and acute phase proteins elevation during aging$442,260
R01 · FY2021 · AG · contact PI
Neutral sphingomyelinase-2 and glucocorticoid receptor$26,415
R01 · FY2021 · AG · contact PI
Ceramide and acute phase proteins elevation during aging$336,600
R01 · FY2020 · AG · contact PI
The Interaction of Interleukin 1b and Glucocorticoid Signaling Pathways in Alzheimer's Disease$382,500
R01 · FY2019 · AG · contact PI
Ceramide and acute phase proteins elevation during aging$336,600
R01 · FY2019 · AG · contact PI
Ceramide and acute phase proteins elevation during aging$320,276
R01 · FY2018 · AG · contact PI
Ceramide and acute phase protein elevation during aging$295,292
R01 · FY2015 · AG · contact PI
Ceramide and acute phase protein elevation during aging$304,425
R01 · FY2014 · AG · contact PI
Ceramide and acute phase protein elevation during aging$287,682
R01 · FY2013 · AG · contact PI
Ceramide and acute phase protein elevation during aging$304,425
R01 · FY2012 · AG · contact PI
Ceramide and acute phase protein elevation during aging$304,425
R01 · FY2011 · AG · contact PI
Role of Neutral Sphingomyelinase-2 in aging$280,070
R01 · FY2011 · AG · contact PI
Role of Neutral Sphingomyelinase-2 in aging$291,375
R01 · FY2010 · AG · contact PI
Ceramide and acute phase protein elevation during aging$377,290
R56 · FY2009 · AG · contact PI
Role of Neutral Sphingomyelinase-2 in aging$294,319
R01 · FY2009 · AG · contact PI
Role of Neutral Sphingomyelinase-2 in aging$294,319
R01 · FY2008 · AG · contact PI
Role of Neutral Sphingomyelinase-2 in aging$286,598
R01 · FY2007 · AG · contact PI
Ceramide and acute phase proteins elevation during aging$245,258
R01 · FY2006 · AG · contact PI
Ceramide and acute phase proteins elevation during aging$251,160
R01 · FY2005 · AG
Ceramide and acute phase proteins elevation during aging$251,160
R01 · FY2004 · AG
Ceramide and acute phase proteins elevation during aging$251,160
R01 · FY2003 · AG
Ceramide and acute phase proteins elevation during aging$276,160
R01 · FY2002 · AG
Ceramide &capacity for growth in aging: a liver aspect$72,400
R03 · FY2001 · AG